{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:49:02Z","timestamp":1790740142823,"version":"4.1.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,5,17]],"date-time":"2017-05-17T00:00:00Z","timestamp":1494979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,5,17]],"date-time":"2017-05-17T00:00:00Z","timestamp":1494979200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Vascular calcification resulting from hyperphosphatemia is a major determinant of mortality in chronic kidney disease (CKD). Vascular calcification is driven by aldosterone-sensitive osteogenic transformation of vascular smooth muscle cells (VSMCs). We show that even in absence of exogenous aldosterone, silencing and pharmacological inhibition (spironolactone, eplerenone) of the mineralocorticoid receptor (MR) ameliorated phosphate-induced osteo-\/chondrogenic transformation of primary human aortic smooth muscle cells (HAoSMCs). High phosphate concentrations up-regulated aldosterone synthase (CYP11B2) expression in HAoSMCs. Silencing and deficiency of CYP11B2 in VSMCs ameliorated phosphate-induced osteogenic reprogramming and calcification. Phosphate treatment was followed by nuclear export of APEX1, a CYP11B2 transcriptional repressor. APEX1 silencing up-regulated <jats:italic>CYP11B2<\/jats:italic> expression and stimulated osteo-\/chondrogenic transformation. APEX1 overexpression blunted the phosphate-induced osteo-\/chondrogenic transformation and calcification of HAoSMCs. <jats:italic>Cyp11b2<\/jats:italic> expression was higher in aortic tissue of hyperphosphatemic klotho-hypomorphic (<jats:italic>kl\/kl<\/jats:italic>) mice than in wild-type mice. In adrenalectomized <jats:italic>kl\/kl<\/jats:italic> mice, spironolactone treatment still significantly ameliorated aortic osteoinductive reprogramming. Our findings suggest that VSMCs express aldosterone synthase, which is up-regulated by phosphate-induced disruption of APEX1-dependent gene suppression. Vascular CYP11B2 may contribute to stimulation of VSMCs osteo-\/chondrogenic transformation during hyperphosphatemia.<\/jats:p>","DOI":"10.1038\/s41598-017-01882-2","type":"journal-article","created":{"date-parts":[[2017,5,11]],"date-time":"2017-05-11T15:27:04Z","timestamp":1494516424000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":62,"title":["Involvement Of Vascular Aldosterone Synthase In Phosphate-Induced Osteogenic Transformation Of Vascular Smooth Muscle Cells"],"prefix":"10.1038","volume":"7","author":[{"given":"Ioana","family":"Alesutan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakob","family":"Voelkl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Feger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise V.","family":"Kratschmar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsiana","family":"Castor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sobuj","family":"Mia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Sacherer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Viereck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Borst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Leibrock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meinrad","family":"Gawaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Kuro-o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Pilz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Tomaschitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6820-2712","authenticated-orcid":false,"given":"Alex","family":"Odermatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burkert","family":"Pieske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9874-8898","authenticated-orcid":false,"given":"Carsten A.","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2962-1540","authenticated-orcid":false,"given":"Florian","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,5,17]]},"reference":[{"key":"1882_CR1","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1161\/CIRCRESAHA.110.234914","volume":"109","author":"CM Shanahan","year":"2011","unstructured":"Shanahan, C. M., Crouthamel, M. H., Kapustin, A. & Giachelli, C. M. Arterial calcification in chronic kidney disease: key roles for calcium and phosphate. Circulation research \n                           109, 697\u2013711, doi:10.1161\/CIRCRESAHA.110.234914 (2011).","journal-title":"Circulation research"},{"key":"1882_CR2","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1161\/hy1001.096358","volume":"38","author":"J Blacher","year":"2001","unstructured":"Blacher, J., Guerin, A. P., Pannier, B., Marchais, S. J. & London, G. M. Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension \n                           38, 938\u2013942, doi:10.1161\/hy1001.096358 (2001).","journal-title":"Hypertension"},{"key":"1882_CR3","doi-asserted-by":"publisher","first-page":"S300","DOI":"10.1097\/01.ASN.0000081663.52165.66","volume":"14","author":"CM Giachelli","year":"2003","unstructured":"Giachelli, C. M. Vascular calcification: in vitro evidence for the role of inorganic phosphate. J Am Soc Nephrol \n                           14, S300\u2013S304, doi:10.1097\/01.ASN.0000081663.52165.66 (2003).","journal-title":"J Am Soc Nephrol"},{"key":"1882_CR4","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1681\/ASN.2008070692","volume":"20","author":"M Mizobuchi","year":"2009","unstructured":"Mizobuchi, M., Towler, D. & Slatopolsky, E. Vascular calcification: the killer of patients with chronic kidney disease. J Am Soc Nephrol \n                           20, 1453\u20131464, doi:10.1681\/ASN.2008070692 (2009).","journal-title":"J Am Soc Nephrol"},{"key":"1882_CR5","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.1161\/CIRCULATIONAHA.105.553198","volume":"112","author":"M Tonelli","year":"2005","unstructured":"Tonelli, M., Sacks, F., Pfeffer, M., Gao, Z. & Curhan, G. Relation between serum phosphate level and cardiovascular event rate in people with coronary disease. Circulation \n                           112, 2627\u20132633, doi:10.1161\/CIRCULATIONAHA.105.553198 (2005).","journal-title":"Circulation"},{"key":"1882_CR6","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1096\/fj.02-0459fje","volume":"17","author":"J Nikolovski","year":"2003","unstructured":"Nikolovski, J., Kim, B. S. & Mooney, D. J. Cyclic strain inhibits switching of smooth muscle cells to an osteoblast-like phenotype. FASEB J \n                           17, 455\u2013457, doi:10.1096\/fj.02-0459fje (2003).","journal-title":"FASEB J"},{"key":"1882_CR7","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1161\/hh2401.101070","volume":"89","author":"SA Steitz","year":"2001","unstructured":"Steitz, S. A. et al. Smooth muscle cell phenotypic transition associated with calcification: upregulation of Cbfa1 and downregulation of smooth muscle lineage markers. Circulation research \n                           89, 1147\u20131154, doi:10.1161\/hh2401.101070 (2001).","journal-title":"Circulation research"},{"key":"1882_CR8","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1161\/01.RES.0000216409.20863.e7","volume":"98","author":"X Li","year":"2006","unstructured":"Li, X., Yang, H. Y. & Giachelli, C. M. Role of the sodium-dependent phosphate cotransporter, Pit-1, in vascular smooth muscle cell calcification. Circulation research \n                           98, 905\u2013912, doi:10.1161\/01.RES.0000216409.20863.e7 (2006).","journal-title":"Circulation research"},{"key":"1882_CR9","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1161\/CIRCULATIONAHA.108.783738","volume":"118","author":"RC Shroff","year":"2008","unstructured":"Shroff, R. C. et al. Dialysis accelerates medial vascular calcification in part by triggering smooth muscle cell apoptosis. Circulation \n                           118, 1748\u20131757, doi:10.1161\/CIRCULATIONAHA.108.783738 (2008).","journal-title":"Circulation"},{"key":"1882_CR10","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1172\/JCI24140","volume":"115","author":"JS Shao","year":"2005","unstructured":"Shao, J. S. et al. Msx2 promotes cardiovascular calcification by activating paracrine Wnt signals. J Clin Invest \n                           115, 1210\u20131220, doi:10.1172\/JCI24140 (2005).","journal-title":"J Clin Invest"},{"key":"1882_CR11","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1002\/jcb.22607","volume":"110","author":"MY Speer","year":"2010","unstructured":"Speer, M. Y., Li, X., Hiremath, P. G. & Giachelli, C. M. Runx2\/Cbfa1, but not loss of myocardin, is required for smooth muscle cell lineage reprogramming toward osteochondrogenesis. J Cell Biochem \n                           110, 935\u2013947, doi:10.1002\/jcb.v110:4 (2010).","journal-title":"J Cell Biochem"},{"key":"1882_CR12","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.ajpath.2010.10.006","volume":"178","author":"A Pai","year":"2011","unstructured":"Pai, A., Leaf, E. M., El-Abbadi, M. & Giachelli, C. M. Elastin degradation and vascular smooth muscle cell phenotype change precede cell loss and arterial medial calcification in a uremic mouse model of chronic kidney disease. The American journal of pathology \n                           178, 764\u2013773, doi:10.1016\/j.ajpath.2010.10.006 (2011).","journal-title":"The American journal of pathology"},{"key":"1882_CR13","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.1093\/ndt\/gfp137","volume":"24","author":"N Koleganova","year":"2009","unstructured":"Koleganova, N. et al. Arterial calcification in patients with chronic kidney disease. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association \n                           24, 2488\u20132496, doi:10.1093\/ndt\/gfp137 (2009).","journal-title":"Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association"},{"key":"1882_CR14","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1681\/ASN.2009060640","volume":"21","author":"RC Shroff","year":"2010","unstructured":"Shroff, R. C. et al. Chronic mineral dysregulation promotes vascular smooth muscle cell adaptation and extracellular matrix calcification. J Am Soc Nephrol \n                           21, 103\u2013112, doi:10.1681\/ASN.2009060640 (2010).","journal-title":"J Am Soc Nephrol"},{"key":"1882_CR15","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1161\/01.RES.0000159937.05502.d1","volume":"96","author":"IZ Jaffe","year":"2005","unstructured":"Jaffe, I. Z. & Mendelsohn, M. E. Angiotensin II and aldosterone regulate gene transcription via functional mineralocortocoid receptors in human coronary artery smooth muscle cells. Circulation research \n                           96, 643\u2013650, doi:10.1161\/01.RES.0000159937.05502.d1 (2005).","journal-title":"Circulation research"},{"key":"1882_CR16","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1161\/01.ATV.0000258414.59393.89","volume":"27","author":"IZ Jaffe","year":"2007","unstructured":"Jaffe, I. Z., Tintut, Y., Newfell, B. G., Demer, L. L. & Mendelsohn, M. E. Mineralocorticoid receptor activation promotes vascular cell calcification. Arteriosclerosis, thrombosis, and vascular biology \n                           27, 799\u2013805, doi:10.1161\/01.ATV.0000258414.59393.89 (2007).","journal-title":"Arteriosclerosis, thrombosis, and vascular biology"},{"key":"1882_CR17","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1258\/ebm.2011.011175","volume":"237","author":"SY Wu","year":"2012","unstructured":"Wu, S. Y. et al. Endogenous aldosterone is involved in vascular calcification in rat. Exp Biol Med (Maywood) \n                           237, 31\u201337, doi:10.1258\/ebm.2011.011175 (2012).","journal-title":"Exp Biol Med (Maywood)"},{"key":"1882_CR18","doi-asserted-by":"publisher","unstructured":"Lang, F., Ritz, E., Alesutan, I. & Voelkl, J. Impact of Aldosterone on Osteoinductive Signaling and Vascular Calcification. Nephron Physiol, doi:10.1159\/000368268 (2014).","DOI":"10.1159\/000368268"},{"key":"1882_CR19","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1093\/ndt\/gft041","volume":"28","author":"F Lang","year":"2013","unstructured":"Lang, F., Ritz, E., Voelkl, J. & Alesutan, I. Vascular calcification\u2013is aldosterone a culprit? Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association \n                           28, 1080\u20131084, doi:10.1093\/ndt\/gft041 (2013).","journal-title":"Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association"},{"key":"1882_CR20","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1172\/JCI64093","volume":"123","author":"J Voelkl","year":"2013","unstructured":"Voelkl, J. et al. Spironolactone ameliorates PIT1-dependent vascular osteoinduction in klotho-hypomorphic mice. J Clin Invest \n                           123, 812\u2013822, doi:10.1172\/JCI64093 (2013).","journal-title":"J Clin Invest"},{"key":"1882_CR21","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1152\/ajprenal.00669.2014","volume":"309","author":"N Tatsumoto","year":"2015","unstructured":"Tatsumoto, N. et al. Spironolactone ameliorates arterial medial calcification in uremic rats: the role of mineralocorticoid receptor signaling in vascular calcification. Am J Physiol Renal Physiol \n                           309, 2014\u201379, doi:10.1152\/ajprenal.00669.2014 (2015).","journal-title":"Am J Physiol Renal Physiol"},{"key":"1882_CR22","doi-asserted-by":"publisher","first-page":"F1171","DOI":"10.1152\/ajprenal.00233.2010","volume":"299","author":"SS Fischer","year":"2010","unstructured":"Fischer, S. S. et al. Hyperaldosteronism in Klotho-deficient mice. Am J Physiol Renal Physiol \n                           299, F1171\u2013F1177, doi:10.1152\/ajprenal.00233.2010 (2010).","journal-title":"Am J Physiol Renal Physiol"},{"key":"1882_CR23","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/ki.1982.14","volume":"21","author":"RJ Hene","year":"1982","unstructured":"Hene, R. J., Boer, P., Koomans, H. A. & Mees, E. J. Plasma aldosterone concentrations in chronic renal disease. Kidney Int \n                           21, 98\u2013101, doi:10.1038\/ki.1982.14 (1982).","journal-title":"Kidney Int"},{"key":"1882_CR24","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.jacc.2013.09.056","volume":"63","author":"Y Matsumoto","year":"2014","unstructured":"Matsumoto, Y. et al. Spironolactone reduces cardiovascular and cerebrovascular morbidity and mortality in hemodialysis patients. Journal of the American College of Cardiology \n                           63, 528\u2013536, doi:10.1016\/j.jacc.2013.09.056 (2014).","journal-title":"Journal of the American College of Cardiology"},{"key":"1882_CR25","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/1745-6215-15-160","volume":"15","author":"NR Hill","year":"2014","unstructured":"Hill, N. R. et al. Benefits of Aldosterone Receptor Antagonism in Chronic Kidney Disease (BARACK D) trial-a multi-centre, prospective, randomised, open, blinded end-point, 36-month study of 2,616 patients within primary care with stage 3b chronic kidney disease to compare the efficacy of spironolactone 25\u2009mg once daily in addition to routine care on mortality and cardiovascular outcomes versus routine care alone: study protocol for a randomized controlled trial. Trials \n                           15, 160, doi:10.1186\/1745-6215-15-160 (2014).","journal-title":"Trials"},{"key":"1882_CR26","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/1745-6215-15-158","volume":"15","author":"KP Ng","year":"2014","unstructured":"Ng, K. P. et al. Spironolactone to prevent cardiovascular events in early-stage chronic kidney disease (STOP-CKD): study protocol for a randomized controlled pilot trial. Trials \n                           15, 158, doi:10.1186\/1745-6215-15-158 (2014).","journal-title":"Trials"},{"key":"1882_CR27","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/S2213-8587(14)70194-9","volume":"2","author":"K Ando","year":"2014","unstructured":"Ando, K. et al. Anti-albuminuric effect of the aldosterone blocker eplerenone in non-diabetic hypertensive patients with albuminuria: a double-blind, randomised, placebo-controlled trial. The lancet. Diabetes & endocrinology \n                           2, 944\u2013953, doi:10.1016\/S2213-8587(14)70194-9 (2014).","journal-title":"The lancet. Diabetes & endocrinology"},{"key":"1882_CR28","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1093\/ndt\/gfq750","volume":"26","author":"J Toyonaga","year":"2011","unstructured":"Toyonaga, J. et al. Spironolactone inhibits hyperglycemia-induced podocyte injury by attenuating ROS production. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association \n                           26, 2475\u20132484, doi:10.1093\/ndt\/gfq750 (2011).","journal-title":"Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association"},{"key":"1882_CR29","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1006\/jmcc.1999.0963","volume":"31","author":"SH Slight","year":"1999","unstructured":"Slight, S. H., Joseph, J., Ganjam, V. K. & Weber, K. T. Extra-adrenal mineralocorticoids and cardiovascular tissue. Journal of molecular and cellular cardiology \n                           31, 1175\u20131184, doi:10.1006\/jmcc.1999.0963 (1999).","journal-title":"Journal of molecular and cellular cardiology"},{"key":"1882_CR30","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1126\/science.3306919","volume":"237","author":"C Le Goascogne","year":"1987","unstructured":"Le Goascogne, C. et al. Neurosteroids: cytochrome P-450scc in rat brain. Science \n                           237, 1212\u20131215, doi:10.1126\/science.3306919 (1987).","journal-title":"Science"},{"key":"1882_CR31","doi-asserted-by":"publisher","first-page":"5118","DOI":"10.1210\/jcem.86.11.8102","volume":"86","author":"CE Gomez-Sanchez","year":"2001","unstructured":"Gomez-Sanchez, C. E. & Gomez-Sanchez, E. P. Editorial: Cardiac steroidogenesis\u2013new sites of synthesis, or much ado about nothing? The Journal of clinical endocrinology and metabolism \n                           86, 5118\u20135120, doi:10.1210\/jcem.86.11.8102 (2001).","journal-title":"The Journal of clinical endocrinology and metabolism"},{"key":"1882_CR32","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1161\/01.HYP.0000175814.18550.c0","volume":"46","author":"C Xue","year":"2005","unstructured":"Xue, C. & Siragy, H. M. Local renal aldosterone system and its regulation by salt, diabetes, and angiotensin II type 1 receptor. Hypertension \n                           46, 584\u2013590, doi:10.1161\/01.HYP.0000175814.18550.c0 (2005).","journal-title":"Hypertension"},{"key":"1882_CR33","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1161\/CIRCULATIONAHA.113.007690","volume":"130","author":"BA Maron","year":"2014","unstructured":"Maron, B. A. et al. Upregulation of steroidogenic acute regulatory protein by hypoxia stimulates aldosterone synthesis in pulmonary artery endothelial cells to promote pulmonary vascular fibrosis. Circulation \n                           130, 168\u2013179, doi:10.1161\/CIRCULATIONAHA.113.007690 (2014).","journal-title":"Circulation"},{"key":"1882_CR34","doi-asserted-by":"publisher","first-page":"15636","DOI":"10.3390\/molecules181215636","volume":"18","author":"Y Matsuzawa","year":"2013","unstructured":"Matsuzawa, Y., Suematsu, S., Saito, J., Omura, M. & Nishikawa, T. Vascular aldosterone production at the pre-diabetic stage of young Otsuka Long-Evans Tokushima Fatty (OLETF) rats, compared with Long-Evans Tokushima Otsuka (LETO) rats. Molecules \n                           18, 15636\u201315647, doi:10.3390\/molecules181215636 (2013).","journal-title":"Molecules"},{"key":"1882_CR35","doi-asserted-by":"crossref","first-page":"24316","DOI":"10.1016\/S0021-9258(19)51084-5","volume":"269","author":"H Hatakeyama","year":"1994","unstructured":"Hatakeyama, H. et al. Vascular aldosterone. Biosynthesis and a link to angiotensin II-induced hypertrophy of vascular smooth muscle cells. The Journal of biological chemistry \n                           269, 24316\u201324320 (1994).","journal-title":"The Journal of biological chemistry"},{"key":"1882_CR36","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1073\/pnas.89.4.1458","volume":"89","author":"T Kawamoto","year":"1992","unstructured":"Kawamoto, T. et al. Role of steroid 11 beta-hydroxylase and steroid 18-hydroxylase in the biosynthesis of glucocorticoids and mineralocorticoids in humans. Proceedings of the National Academy of Sciences of the United States of America \n                           89, 1458\u20131462, doi:10.1073\/pnas.89.4.1458 (1992).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"1882_CR37","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1210\/me.2012-1287","volume":"27","author":"N Strushkevich","year":"2013","unstructured":"Strushkevich, N. et al. Structural insights into aldosterone synthase substrate specificity and targeted inhibition. Mol Endocrinol \n                           27, 315\u2013324, doi:10.1210\/me.2012-1287 (2013).","journal-title":"Mol Endocrinol"},{"key":"1882_CR38","doi-asserted-by":"publisher","first-page":"3626","DOI":"10.1210\/en.2004-0081","volume":"145","author":"N Ahmad","year":"2004","unstructured":"Ahmad, N., Romero, D. G., Gomez-Sanchez, E. P. & Gomez-Sanchez, C. E. Do human vascular endothelial cells produce aldosterone? Endocrinology \n                           145, 3626\u20133629, doi:10.1210\/en.2004-0081 (2004).","journal-title":"Endocrinology"},{"key":"1882_CR39","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1007\/s00109-014-1193-7","volume":"92","author":"H Ayari","year":"2014","unstructured":"Ayari, H. et al. Mutual amplification of corticosteroids and angiotensin systems in human vascular smooth muscle cells and carotid atheroma. Journal of molecular medicine \n                           92, 1201\u20138, doi:10.1007\/s00109-014-1193-7 (2014).","journal-title":"Journal of molecular medicine"},{"key":"1882_CR40","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1038\/hr.2009.76","volume":"32","author":"T Ohmine","year":"2009","unstructured":"Ohmine, T. et al. The involvement of aldosterone in cyclic stretch-mediated activation of NADPH oxidase in vascular smooth muscle cells. Hypertension research: official journal of the Japanese Society of Hypertension \n                           32, 690\u2013699, doi:10.1038\/hr.2009.76 (2009).","journal-title":"Hypertension research: official journal of the Japanese Society of Hypertension"},{"key":"1882_CR41","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1161\/CIRCRESAHA.111.262931","volume":"111","author":"F McManus","year":"2012","unstructured":"McManus, F. et al. APEX1 regulation of aldosterone synthase gene transcription is disrupted by a common polymorphism in humans. Circulation research \n                           111, 212\u2013219, doi:10.1161\/CIRCRESAHA.111.262931 (2012).","journal-title":"Circulation research"},{"key":"1882_CR42","doi-asserted-by":"publisher","unstructured":"Leibrock, C. B. et al. Prevention of tissue calcification in klotho-hypomorphic mice by NH4Cl-treatment. J Am Soc Nephrol \n                           26, 2423\u201333, doi:10.1681\/ASN.2014030230 (2015).","DOI":"10.1681\/ASN.2014030230"},{"key":"1882_CR43","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1161\/01.HYP.29.1.45","volume":"29","author":"Y Takeda","year":"1997","unstructured":"Takeda, Y. et al. Vascular aldosterone in genetically hypertensive rats. Hypertension \n                           29, 45\u201348, doi:10.1161\/01.HYP.29.1.45 (1997).","journal-title":"Hypertension"},{"key":"1882_CR44","doi-asserted-by":"publisher","first-page":"4015","DOI":"10.1096\/fj.14-250282","volume":"28","author":"S Korte","year":"2014","unstructured":"Korte, S. et al. Feedforward activation of endothelial ENaC by high sodium. FASEB J \n                           28, 4015\u20134025, doi:10.1096\/fj.14-250282 (2014).","journal-title":"FASEB J"},{"key":"1882_CR45","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1096\/fj.14-259606","volume":"30","author":"P Jeggle","year":"2016","unstructured":"Jeggle, P., Hofschroer, V., Maase, M., Bertog, M. & Kusche-Vihrog, K. Aldosterone synthase knockout mouse as a model for sodium-induced endothelial sodium channel up-regulation in vascular endothelium. FASEB J \n                           30, 45\u201353, doi:10.1096\/fj.14-259606 (2016).","journal-title":"FASEB J"},{"key":"1882_CR46","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1159\/000355728","volume":"37","author":"I Alesutan","year":"2013","unstructured":"Alesutan, I. et al. 25-Hydroxyvitamin D3 1-alpha-hydroxylase-dependent stimulation of renal klotho expression by spironolactone. Kidney & blood pressure research \n                           37, 475\u2013487, doi:10.1159\/000355728 (2013).","journal-title":"Kidney & blood pressure research"},{"key":"1882_CR47","doi-asserted-by":"publisher","unstructured":"Zhu, D., Rashdan, N. A., Chapman, K. E., Hadoke, P. W. & MacRae, V. E. A novel role for the mineralocorticoid receptor in glucocorticoid driven vascular calcification. Vascular pharmacology, doi:10.1016\/j.vph.2016.04.005 (2016).","DOI":"10.1016\/j.vph.2016.04.005"},{"key":"1882_CR48","doi-asserted-by":"publisher","first-page":"24807","DOI":"10.1038\/srep24807","volume":"6","author":"D Zhu","year":"2016","unstructured":"Zhu, D. et al. Ablation of the androgen receptor from vascular smooth muscle cells demonstrates a role for testosterone in vascular calcification. Sci Rep \n                           6, 24807, doi:10.1038\/srep24807 (2016).","journal-title":"Sci Rep"},{"key":"1882_CR49","doi-asserted-by":"publisher","first-page":"7537","DOI":"10.1074\/jbc.M109.055087","volume":"285","author":"BK Son","year":"2010","unstructured":"Son, B. K. et al. Androgen receptor-dependent transactivation of growth arrest-specific gene 6 mediates inhibitory effects of testosterone on vascular calcification. The Journal of biological chemistry \n                           285, 7537\u20137544, doi:10.1074\/jbc.M109.055087 (2010).","journal-title":"The Journal of biological chemistry"},{"key":"1882_CR50","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3389\/fphys.2015.00269","volume":"6","author":"MA Silva","year":"2015","unstructured":"Silva, M. A. et al. Spironolactone treatment attenuates vascular dysfunction in type 2 diabetic mice by decreasing oxidative stress and restoring NO\/GC signaling. Front Physiol \n                           6, 269, doi:10.3389\/fphys.2015.00269 (2015).","journal-title":"Front Physiol"},{"key":"1882_CR51","doi-asserted-by":"publisher","first-page":"7416","DOI":"10.1016\/j.biomaterials.2014.05.034","volume":"35","author":"A Assmann","year":"2014","unstructured":"Assmann, A. et al. The degeneration of biological cardiovascular prostheses under pro-calcific metabolic conditions in a small animal model. Biomaterials \n                           35, 7416\u20137428, doi:10.1016\/j.biomaterials.2014.05.034 (2014).","journal-title":"Biomaterials"},{"key":"1882_CR52","doi-asserted-by":"publisher","first-page":"2522","DOI":"10.1093\/nar\/gkl1163","volume":"35","author":"J Qu","year":"2007","unstructured":"Qu, J., Liu, G. H., Huang, B. & Chen, C. Nitric oxide controls nuclear export of APE1\/Ref-1 through S-nitrosation of cysteines 93 and 310. Nucleic acids research \n                           35, 2522\u20132532, doi:10.1093\/nar\/gkl1163 (2007).","journal-title":"Nucleic acids research"},{"key":"1882_CR53","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.bbrc.2013.04.101","volume":"435","author":"S Choi","year":"2013","unstructured":"Choi, S. et al. Histone deacetylases inhibitor trichostatin A modulates the extracellular release of APE1\/Ref-1. Biochemical and biophysical research communications \n                           435, 403\u2013407, doi:10.1016\/j.bbrc.2013.04.101 (2013).","journal-title":"Biochemical and biophysical research communications"},{"key":"1882_CR54","doi-asserted-by":"publisher","first-page":"538","DOI":"10.5551\/jat.15826","volume":"20","author":"T Azechi","year":"2013","unstructured":"Azechi, T. et al. Trichostatin A, an HDAC class I\/II inhibitor, promotes Pi-induced vascular calcification via up-regulation of the expression of alkaline phosphatase. Journal of atherosclerosis and thrombosis \n                           20, 538\u2013547, doi:10.5551\/jat.15826 (2013).","journal-title":"Journal of atherosclerosis and thrombosis"},{"key":"1882_CR55","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s11906-014-0427-y","volume":"16","author":"JB Koenig","year":"2014","unstructured":"Koenig, J. B. & Jaffe, I. Z. Direct role for smooth muscle cell mineralocorticoid receptors in vascular remodeling: novel mechanisms and clinical implications. Current hypertension reports \n                           16, 427, doi:10.1007\/s11906-014-0427-y (2014).","journal-title":"Current hypertension reports"},{"key":"1882_CR56","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1038\/sj.ki.5001854","volume":"70","author":"S Bianchi","year":"2006","unstructured":"Bianchi, S., Bigazzi, R. & Campese, V. M. Long-term effects of spironolactone on proteinuria and kidney function in patients with chronic kidney disease. Kidney Int \n                           70, 2116\u20132123, doi:10.1038\/sj.ki.5001854 (2006).","journal-title":"Kidney Int"},{"key":"1882_CR57","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1681\/ASN.2013111156","volume":"26","author":"A Todkar","year":"2015","unstructured":"Todkar, A. et al. Mechanisms of renal control of potassium homeostasis in complete aldosterone deficiency. J Am Soc Nephrol \n                           26, 425\u2013438, doi:10.1681\/ASN.2013111156 (2015).","journal-title":"J Am Soc Nephrol"},{"key":"1882_CR58","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1083\/jcb.102.2.343","volume":"102","author":"GK Owens","year":"1986","unstructured":"Owens, G. K., Loeb, A., Gordon, D. & Thompson, M. M. Expression of smooth muscle-specific alpha-isoactin in cultured vascular smooth muscle cells: relationship between growth and cytodifferentiation. J Cell Biol \n                           102, 343\u2013352, doi:10.1083\/jcb.102.2.343 (1986).","journal-title":"J Cell Biol"},{"key":"1882_CR59","doi-asserted-by":"publisher","first-page":"C210","DOI":"10.1152\/ajpcell.00229.2010","volume":"300","author":"R Villa-Bellosta","year":"2011","unstructured":"Villa-Bellosta, R., Millan, A. & Sorribas, V. Role of calcium-phosphate deposition in vascular smooth muscle cell calcification. Am J Physiol Cell Physiol \n                           300, C210\u2013220, doi:10.1152\/ajpcell.00229.2010 (2011).","journal-title":"Am J Physiol Cell Physiol"},{"key":"1882_CR60","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s00424-012-1145-4","volume":"464","author":"A Todkar","year":"2012","unstructured":"Todkar, A. et al. Aldosterone deficiency adversely affects pregnancy outcome in mice. Pflugers Arch \n                           464, 331\u2013343, doi:10.1007\/s00424-012-1145-4 (2012).","journal-title":"Pflugers Arch"},{"key":"1882_CR61","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/36285","volume":"390","author":"M Kuro-o","year":"1997","unstructured":"Kuro-o, M. et al. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature \n                           390, 45\u201351, doi:10.1038\/36285 (1997).","journal-title":"Nature"},{"key":"1882_CR62","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1093\/cvr\/cvw062","volume":"110","author":"I Alesutan","year":"2016","unstructured":"Alesutan, I. et al. Augmentation of phosphate-induced osteo-\/chondrogenic transformation of vascular smooth muscle cells by homoarginine. Cardiovasc Res \n                           110, 408\u2013418, doi:10.1093\/cvr\/cvw062 (2016).","journal-title":"Cardiovasc Res"},{"key":"1882_CR63","doi-asserted-by":"publisher","unstructured":"Strajhar, P. et al. Acute Effects of Lysergic Acid Diethylamide on Circulating Steroid Levels in Healthy Subjects. J Neuroendocrinol \n                           28, doi:10.1111\/jne.12374 (2016).","DOI":"10.1111\/jne.12374"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-01882-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-01882-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-01882-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T04:22:59Z","timestamp":1671769379000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-01882-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,17]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["1882"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-01882-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,17]]},"assertion":[{"value":"25 November 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"2059"}}